Iambic Therapeutics
AI-driven drug discovery company developing novel medicines for unmet patient needs.
About
Technology stack
detected 2026-06-19No comments yet. Be the first to share your take.
What does Iambic Therapeutics do?
Iambic Therapeutics is a clinical-stage life science and technology company that develops novel medicines using its AI-driven discovery and development platform. Founded in 2019, the company integrates artificial intelligence with physics principles to tackle complex molecular design challenges, aiming to accelerate drug discovery timelines and reduce development risks for pharmaceutical and biotech organizations.
How much funding has Iambic Therapeutics raised?
Iambic Therapeutics has raised a total of $50M in funding. The most recent round on record is Series B Extension.
Where is Iambic Therapeutics headquartered?
Iambic Therapeutics is headquartered in San Diego, United States.
When was Iambic Therapeutics founded?
Iambic Therapeutics was founded in 2019.
What industry does Iambic Therapeutics operate in?
Iambic Therapeutics operates in Biotech, HealthTech, Drug Discovery, AI-Driven Drug Discovery, Foundation Model, Generative AI.
How many employees does Iambic Therapeutics have?
Iambic Therapeutics has approximately 151 people on record.